These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37130516)

  • 1. Reconstruction of tumor microenvironment via
    Zhou Z; He J; Pang Y; Sun W
    Biofabrication; 2023 May; 15(3):. PubMed ID: 37130516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer models: Engineering the tumor microenvironment.
    Bahcecioglu G; Basara G; Ellis BW; Ren X; Zorlutuna P
    Acta Biomater; 2020 Apr; 106():1-21. PubMed ID: 32045679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D In Vitro Model (R)evolution: Unveiling Tumor-Stroma Interactions.
    Rodrigues J; Heinrich MA; Teixeira LM; Prakash J
    Trends Cancer; 2021 Mar; 7(3):249-264. PubMed ID: 33218948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaffold-based 3D cell culture models in cancer research.
    Abuwatfa WH; Pitt WG; Husseini GA
    J Biomed Sci; 2024 Jan; 31(1):7. PubMed ID: 38221607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?
    Hoarau-Véchot J; Rafii A; Touboul C; Pasquier J
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29346265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicellular 3D Models to Study Tumour-Stroma Interactions.
    Colombo E; Cattaneo MG
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualizing Extracellular Vesicles and Their Function in 3D Tumor Microenvironment Models.
    Ural EE; Toomajian V; Hoque Apu E; Veletic M; Balasingham I; Ashammakhi N; Kanada M; Contag CH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in spheroid-based microfluidic models to mimic the tumour microenvironment.
    Ro J; Kim J; Cho YK
    Analyst; 2022 May; 147(10):2023-2034. PubMed ID: 35485712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-chip recapitulation of the tumor microenvironment: A decade of progress.
    Giannitelli SM; Peluzzi V; Raniolo S; Roscilli G; Trombetta M; Mozetic P; Rainer A
    Biomaterials; 2024 Apr; 306():122482. PubMed ID: 38301325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The third dimension of tumor microenvironment-The importance of tumor stroma in 3D cancer models.
    Plava J; Cehakova M; Kuniakova M; Trnkova L; Cihova M; Bohac M; Danisovic L
    Exp Biol Med (Maywood); 2023 Aug; 248(15):1347-1358. PubMed ID: 37750028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
    Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
    Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered 3D ex vivo models to recapitulate the complex stromal and immune interactions within the tumor microenvironment.
    Ravi K; Manoharan TJM; Wang KC; Pockaj B; Nikkhah M
    Biomaterials; 2024 Mar; 305():122428. PubMed ID: 38147743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioengineering-inspired three-dimensional culture systems: Organoids to create tumor microenvironment.
    Saglam-Metiner P; Gulce-Iz S; Biray-Avci C
    Gene; 2019 Feb; 686():203-212. PubMed ID: 30481551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling.
    Shukla P; Yeleswarapu S; Heinrich MA; Prakash J; Pati F
    Biofabrication; 2022 May; 14(3):. PubMed ID: 35512666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of the tumor microenvironment using a reconfigurable microfluidic cell culture platform.
    Sethakorn N; Heninger E; Breneman MT; Recchia E; Ding AB; Jarrard DF; Hematti P; Beebe DJ; Kosoff D
    FASEB J; 2022 Oct; 36(10):e22540. PubMed ID: 36083096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models.
    Ringquist R; Ghoshal D; Jain R; Roy K
    Adv Drug Deliv Rev; 2021 Dec; 179():114003. PubMed ID: 34653533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D bioprinting of gastrointestinal cancer models: A comprehensive review on processing, properties, and therapeutic implications.
    Prashantha K; Krishnappa A; Muthappa M
    Biointerphases; 2023 Mar; 18(2):020801. PubMed ID: 36963961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D modeling in cancer studies.
    Atat OE; Farzaneh Z; Pourhamzeh M; Taki F; Abi-Habib R; Vosough M; El-Sibai M
    Hum Cell; 2022 Jan; 35(1):23-36. PubMed ID: 34761350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
    Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
    Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic 3D cell culture: State of the art and current advances.
    Caleffi JT; Aal MCE; Gallindo HOM; Caxali GH; Crulhas BP; Ribeiro AO; Souza GR; Delella FK
    Life Sci; 2021 Dec; 286():120028. PubMed ID: 34627776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.